Shingrix - An Adjuvanted, Recombinant Herpes Zoster Vaccine

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2017年 / 59卷 / 1535期
关键词：
SUBUNIT VACCINE; EFFICACY;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [41] A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
    Yih, W. Katherine
    Kulldorff, Martin
    Dashevsky, Inna
    Maro, Judith C.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2022, 191 (05) : 957 - 964
  • [42] Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
    Le, Phuc
    Rothberg, Michael B.
    JAMA INTERNAL MEDICINE, 2018, 178 (02) : 248 - 258
  • [43] A critical appraisal of "Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus
    Bharucha, Tehmina
    Ming, Damien
    Breuer, Judith
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1789 - 1797
  • [44] Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
    Proano, Diana Alexandra Echeverria
    Zhu, Fengcai
    Sun, Xiaodong
    Zoco, Jesus
    Soni, Jyoti
    Parmar, Neeraj
    Ali, S. Omar
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [45] Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
    Fernanda Tavares-Da-Silva
    Olivia Mahaux
    Lionel Van Holle
    François Haguinet
    Harry Seifert
    Jens-Ulrich Stegmann
    Drug Safety, 2020, 43 : 1223 - 1234
  • [46] Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
    Tavares-Da-Silva, Fernanda
    Mahaux, Olivia
    Van Holle, Lionel
    Haguinet, Francois
    Seifert, Harry
    Stegmann, Jens-Ulrich
    DRUG SAFETY, 2020, 43 (12) : 1223 - 1234
  • [47] ADJUVANTED RECOMBINANT ZOSTER VACCINE IN IMMUNE MEDIATED INFLAMMATORY DISEASES: A SYSTEMATIC REVIEW
    Zamora, Natalia V.
    Sorrentino, Laura
    Cosentino, Vanesa
    Schneeberger, Emilce
    Citera, Gustavo
    de la Vega, Maria
    Silvia Larroude, Maria
    Vazquez, Hebe
    Bonvehi, Pablo
    Nacinovich, Francisco
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S55 - S55
  • [48] Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020
    Orru', Stefano
    Bierbaum, Sibylle
    Enk, Alexander
    Hengel, Hartmut
    Hoffelner, Marcus
    Huzly, Daniela
    Keller-Stanislawski, Brigitte
    Mahler, Vera
    Mockenhaupt, Maja
    Oberle, Doris
    EUROSURVEILLANCE, 2023, 28 (50)
  • [49] Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview
    Dagnew, Alemnew F.
    Vink, Peter
    Drame, Mamadou
    Willer, David O.
    Salaun, Bruno
    Schuind, Anne E.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4132 - 4143
  • [50] Herpes zoster ophthalmicus: Recombinant vaccine shows high efficacy
    Bitzer, Michaela
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2022, 239 (06) : 743 - +
12345